drug discovery
FyMed Announces Notice of Allowance for US Patent Covering Fy10 Technology Platform
15/05/15 09:00 Filed in: patent | drug discovery | precision medicine | anti-inflammatory | immunomodulatory | Novel | FY10
FyMed Inc., a specialty pharmaceutical company focused on the development and commercialization of novel therapeutics announced that its application covering the Fy10 technology platform was allowed for issuance as a new patent by the USPTO. Read More...
Early Release: FyMed Gets Patent for Novel Immunomodulatory Drug
Pharmaceutical firm FyMed Inc. has received a patent for a novel immunomodulatory drug used in the treatment of autoimmune diseases.
Read More...
Read More...
FyMed Reinforces Its Drug Development Pipeline With Novel Strategies in Precision Medicine
02/10/12 02:16 Filed in: pharmaceutical company | biotechnology company | precision medicine | drug discovery | personalized medicine
FyMed, Inc., a pharmaceutical company utilizing proprietary methodologies in evidence-based medicine for drug discoveries recently announced plans for the strategic and operational reinforcements of their drug development pipeline through innovative approaches in precision medicine. Read More...